Exploring the Growing U.S. Reliance on China's Biotech and Pharmaceutical Products

Wednesday, July 31, 2019

Russell Senate Office Building 428A

Unable to see this video? Click here.

9:30 AM – 9:35 AM: Opening Remarks: Senator Jim Talent and Commissioner Michael Wessel

9:35 AM – 10:20 AM: Panel I: Administration Views on Chinese Pharmaceutical, Medical Product, and Biotechnology Development and Sourcing

Christopher Priest, Chief of Staff, Defense Health Agency Operations Directorate (J-3) [Testimony]
Mark Abdoo, Associate Commissioner for Global Policy and Strategy, Food and Drug Administration [Statement for the Record]

10:35: AM – 12:35 PM: Panel II: China’s Role in Global Health and Activities in the United States

Rosemary Gibson, Senior Advisor, Hastings Center, Author, “China Rx” [Testimony]
Ben Westhoff, Author, “Fentanyl, Inc.” [Testimony]
Dr. Jennifer Bouey, Tang Chair in China Policy Studies, RAND Corporation; Associate Professor, Georgetown University’s School of Nursing and Health Studies [Testimony]
Dr. Mark Kazmierczak, Scientist and Associate, Gryphon Scientific LLC [Testimony]

12:35 PM – 1:30 PM: Lunch Break

1:30 PM – 3:30 PM: Panel III: U.S.-China Links in Health and Medical Products: Risks and Opportunities

Benjamin Shobert, Director of Strategy for Health Business Strategy, Microsoft; Senior Associate, National Bureau of Asian Research [Testimony]
Katherine Eban, Author, “Bottle of Lies” [Testimony]
Dr. Yanzhong Huang, Senior Fellow for Global Health, Council on Foreign Relations; Professor, School of Diplomacy and International Relations, Seton Hall University [Testimony]
Craig Allen, President, US-China Business Council [Testimony]

3:35 PM: Adjourn

Transcript